Home > Products > Pharmaceuticals & Life Science > Pharmaceutical Intermediates > (S)-6-(3-CHLORO-2-FLUOROBENZYL)-1-(1-HYDROXY-3-METHYLBUTAN-2-YL)-7-METHOXY-4-OXO-1,4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID
(S)-6-(3-CHLORO-2-FLUOROBENZYL)-1-(1-HYDROXY-3-METHYLBUTAN-2-YL)-7-METHOXY-4-OXO-1,4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID structure, CAS 697761-98-1

(S)-6-(3-CHLORO-2-FLUOROBENZYL)-1-(1-HYDROXY-3-METHYLBUTAN-2-YL)-7-METHOXY-4-OXO-1,4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID

CAS Number697761-98-1

SynonymsUNII-4GDQ854U53; Elvitegravir; MFCD11846134; GS9137

Molecular FormulaC23H23ClFNO5

Molecular Weight447.88

Purity≥98 (HPLC)%

Density1.4±0.1 g/cm3

Boiling Point623.6±55.0 °C at 760 mmHg

Melting Point93-96°C

Flash Point

Appearancepowder

EINECS

MSDSChineseEnglish

Symbol

Signal Word

Cat. No.: 2A-9092737 Purity: ≥98 (HPLC)%
Change View

Please Login or Create an Account to: See VlP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

Quality Control of [ 697761-98-1 ] Purity: ≥98 (HPLC)% SDS Specification MoL

Chemical & Physical Properties
CAS Number697761-98-1
Catalog No.2A-9092737
Chinese Name埃替拉韦
SynonymsUNII-4GDQ854U53; Elvitegravir; MFCD11846134; GS9137
Molecular FormulaC23H23ClFNO5
Molecular Weight447.88
Purity≥98 (HPLC)
Density1.4±0.1 g/cm3
Boiling Point623.6±55.0 °C at 760 mmHg
Melting Point93-96°C
Appearancepowder
Storage ConditionRefrigerator
ApplicationElvitegravir is an HIV integrase inhibitor with IC50 of 0.7 nM, 2.8 nM and 1.4 nM for HIV-1IIIB, HIV-2EHO and HIV-2ROD respectively.
PubChem ID7843482
MDL NumberMFCD11846134
SMILESFc1c(cccc1Cc2cc3c([n](cc([c]3=O)C(=O)O)[C@H](CO)C(C)C)cc2OC)Cl
InChI1S/C23H23ClFNO5/c1-12(2)19(11-27)26-10-16(23(29)30)22(28)15-8-14(20(31-3)9-18(15)26)7-13-5-4-6-17(24)21(13)25/h4-6,8-10,12,19,27H,7,11H2,1-3H3,(H,29,30)/t19-/m1/s1
InChI KeyJUZYLCPPVHEVSV-LJQANCHMSA-N
NACRES CodeNA.25
UNSPSC51111800
MSDSmsds/92737_1_697761_98_1.pdf
Transport InfoProduct name: Elvitegravir(GS-9137,JTK-303)
Contact Us

Phone:

630-322-8886

630-322-8887

Email:

[email protected]

Office Locations:

Chicago, IL, USA

San Francisco, CA, USA